BNF 85 (British National Formulary)

BNF 85 includes extensive content updates, including:

New monographs for:

• Drovelis® [drospirenone with estetrol] for hormonal contraception
• Xerava® [eravacycline] for complicated intra-abdominal infections
• Netildex® [dexamethasone with netilmicin] for local treatment of eye inflammation and bacterial infection
• Aklief® [trifarotene] for acne vulgaris
• Vydura® [rimegepant] for treatment or prophylaxis of migraine
• Nettacin® [netilmicin] for local treatment of eye infection
• Tenkasi® [oritavancin] for acute bacterial skin and skin structure infections
• Magnesium citrate for treatment and prevention of magnesium deficiency
• Ducressa® [dexamethasone with levofloxacin] for prophylaxis or treatment of postoperative inflammation, or prevention of infection, following cataract surgery
• Sibnayal® [potassium citrate with potassium bicarbonate] for distal renal tubular acidosis
• Kerendia® [finerenone] for chronic kidney disease associated with type 2 diabetes

Other significant changes can be found in British National Formulary 85th, include:

• Guidelines for the prevention of intrauterine infection during preterm prelabour rupture of membranes and antibacterials for the prevention of secondary cases of diphtheria.
• Post-exposure prophylaxis of herpesvirus infections
• COVID-19 vaccines
• Management of epilepsy
• Contraceptive interactions
• Prescribing of drugs associated with dependence and withdrawal
• Management of depression
• A review of the indications and doses of valaciclovir in line with the UK Health Security Agency’s recommendations for post-exposure prophylaxis against chickenpox and shingles comes out today
• Diphtheria vaccine
• Management of gout
• Management of hypertension in patients with type 1 diabetes
• Management of multiple sclerosis
• Preterm labor
• Post-exposure prophylaxis of herpesvirus infections
• Tacrolimus: updated pregnancy, breast-feeding and monitoring advice
• Type 1 diabetes: inclusion of continuous glucose monitoring in aims of treatment
• Type 2 diabetes: use of non-insulin antidiabetic drugs
• Hydrocortisone: addition of children’s dosing for adrenal crisis